Cargando…
Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation
By evaluating risks of late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation (HSCT) in Japan, we clarified what we should focus on during follow-up to reduce them. The study cohort included 6,780 patients who had survived for ≥2 years a...
Autores principales: | Iida, Minako, Nakasone, Hideki, Yamashita, Takuya, Inoue, Masami, Ishida, Yasushi, Uchiyama, Hitoji, Katayama, Yuta, Miyamoto, Toshihiro, Yoshioka, Satoshi, Shiratori, Souichi, Mori, Takehiko, Sawa, Masashi, Sugio, Yasuhiro, Fukuda, Takahiro, Ichinohe, Tatsuo, Atsuta, Yoshiko, Inamoto, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia-Pacific Blood and Marrow Transplantation Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352032/ https://www.ncbi.nlm.nih.gov/pubmed/37465377 http://dx.doi.org/10.31547/bct-2019-011 |
Ejemplares similares
-
Long-term follow-up of patients with ATL after autologous stem cell transplantation
por: Utsunomiya, Atae, et al.
Publicado: (2022) -
Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome‐positive acute lymphoblastic leukemia
por: Akahoshi, Yu, et al.
Publicado: (2019) -
Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?
por: Konuma, Takaaki, et al.
Publicado: (2023) -
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine
por: Shimazu, Yutaka, et al.
Publicado: (2021) -
P1306: IMPACT OF HLA DISPARITY ON THE RISK OF OVERALL MORTALITY IN PATIENTS WITH EXTENSIVE CHRONIC GVHD
por: Fuji, Shigeo, et al.
Publicado: (2023)